Estudios originales
Published on 13 de julio de 2026 | http://doi.org/10.5867/medwave.2026.06.3200
Fear of cancer recurrence and quality of life in early breast cancer survivors: association with clinical and sociodemographic characteristics
Back to article
PROMIS scale scores by category of fear of recurrence.
| < 0.001 | ||||
| Low | 133 | 50.8 (37.4 to 54.1) | ||
| Moderate | 63 | 37.4 (37.4 to 37.4) | ||
| High | 105 | 37.4 (29.6 to 39.8) | ||
| < 0.001 | ||||
| Low | 133 | 53.3 (43.5 to 53.3) | ||
| Moderate | 63 | 43.5 (43.5 to 43.5) | ||
| High | 105 | 43.5 (33.8 to 43.5) | ||
| < 0.001 | ||||
| Low | 133 | 4.0 (3.0 to 4.0) | ||
| Moderate | 63 | 3.0 (3.0 to 3.0) | ||
| High | 105 | 3.0 (2.0 to 3.0) | ||
| < 0.001 | ||||
| Low | 133 | 4.0 (3.0 to 4.0) | ||
| Moderate | 63 | 3.0 (3.0 to 3.0) | ||
| High | 105 | 3.0 (2.0 to 3.0) |
IQR, interquartile range.PROMIS, Patient-Reported Outcomes Measurement Information System.
Source: Prepared by the authors based on the study results.